These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21854519)

  • 41. New DTC guidelines please drug companies, anger critics.
    Med Health; 2005 Aug; 59(27):5-6. PubMed ID: 16111080
    [No Abstract]   [Full Text] [Related]  

  • 42. The exploratory IND.
    Mills G
    J Nucl Med; 2008 Jun; 49(6):45N-47N. PubMed ID: 18511824
    [No Abstract]   [Full Text] [Related]  

  • 43. Uneasy alliance--clinical investigators and the pharmaceutical industry.
    Bodenheimer T
    N Engl J Med; 2000 May; 342(20):1539-44. PubMed ID: 10816196
    [No Abstract]   [Full Text] [Related]  

  • 44. Draft guidance for industry; exports and imports under the FDA Export Reform and Enhancement Act of 1996--FDA. Notice.
    Fed Regist; 1998 Jun; 63(113):32219-34. PubMed ID: 10180275
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Struggling with the rule: the exception from informed consent in resuscitation research.
    Biros M
    Acad Emerg Med; 2007 Apr; 14(4):344-5. PubMed ID: 17400997
    [No Abstract]   [Full Text] [Related]  

  • 46. International research agreement leads to new U.S. guidelines.
    Maloney DM
    Hum Res Rep; 1995 Apr; 10(4):1-2. PubMed ID: 11654182
    [No Abstract]   [Full Text] [Related]  

  • 47. Federal agency revises rule on financial disclosure by researchers.
    Maloney DM
    Hum Res Rep; 1999 Feb; 14(2):1-2. PubMed ID: 11657602
    [No Abstract]   [Full Text] [Related]  

  • 48. Strengthening the regulation of clinical trials and bioresearch monitoring.
    FDA Consum; 2006; 40(6):35. PubMed ID: 17333566
    [TBL] [Abstract][Full Text] [Related]  

  • 49. FDA regulations and guidelines.
    Rothschild A
    J Parenter Sci Technol; 1990; 44(1):26-9. PubMed ID: 2313489
    [No Abstract]   [Full Text] [Related]  

  • 50. Industry perspectives on ICH guidelines.
    Rockhold FW
    Stat Med; 2002 Oct; 21(19):2949-57. PubMed ID: 12325111
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The "truth" in research: setting realistic expectations about outcomes.
    Kozma CM
    Manag Care Interface; 2004 Jul; 17(7):36-7. PubMed ID: 15341246
    [No Abstract]   [Full Text] [Related]  

  • 52. Food and Drug Administration regulation and evaluation of vaccines.
    Marshall V; Baylor NW
    Pediatrics; 2011 May; 127 Suppl 1():S23-30. PubMed ID: 21502242
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FDA. Proposed guidelines for emergency research aim to quell confusion.
    Couzin J
    Science; 2006 Sep; 313(5792):1372-3. PubMed ID: 16959979
    [No Abstract]   [Full Text] [Related]  

  • 54. Progress report on the guidance for industry for statistical aspects of the design, analysis, and interpretation of chronic rodent carcinogenicity studies of pharmaceuticals.
    Lin KK
    J Biopharm Stat; 2000 Nov; 10(4):481-501. PubMed ID: 11104389
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Food and Drug Administration proposed testing guidelines for developmental toxicity studies. Revision Committee. FDA Guidelines for Developmental Toxicity and Reproduction, Food and Drug Administration.
    Collins TF; Sprando RL; Shackelford ME; Hansen DK; Welsh JJ
    Regul Toxicol Pharmacol; 1999 Aug; 30(1):39-44. PubMed ID: 10464045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preparing for an FDA preapproval inspection.
    Blackmer RA
    Qual Assur; 1994 Dec; 3(4):389-403. PubMed ID: 7613749
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003.
    Cowden AL; Katz KA
    Br J Dermatol; 2006 May; 154(5):950-8. PubMed ID: 16634900
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Urological research within the pharmaceutical industry: back to basics?
    Wyllie MG
    BJU Int; 2004 Jun; 93(9):1349-50. PubMed ID: 15180636
    [No Abstract]   [Full Text] [Related]  

  • 59. Direct-to-consumer prescription drug advertising.
    Terzian TV
    Am J Law Med; 1999; 25(1):149-67. PubMed ID: 10207573
    [No Abstract]   [Full Text] [Related]  

  • 60. A survey of developments in food and drug law from July 1998 to November 1999.
    Littlefield N; Hada NR
    Food Drug Law J; 2000; 55(1):35-56. PubMed ID: 12296348
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.